Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

520
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
520
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

573
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
573
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

271
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
271
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

766
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
766
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

298
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
298
Administering Oxygen by Mask01:30

Administering Oxygen by Mask

1.3K
Administering Oxygen by Mask
Administering oxygen by mask is a common nursing intervention that provides supplemental oxygen to patients with respiratory distress or chronic lung conditions. This procedure involves delivering oxygen at a specified rate through a face mask connected to an oxygen source.
Equipment
The equipment necessary for this procedure includes:
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The six phases of prolonged veno-venous extracorporeal membrane oxygenator support: a conceptual framework.

Critical care (London, England)·2026
Same author

Consensus statement on the need for a specialist service for paediatric saliva control in neurodevelopmental disabilities.

Archives of disease in childhood·2025
Same author

Red blood cell transfusion in veno-arterial extracorporeal membrane oxygenation - the disconnect between oxygen delivery and tissue oxygenation.

Perfusion·2025
Same author

Longitudinal cohort study investigating neurodevelopmental and socioemotional outcomes in school-entry aged children after open heart surgery in Australia and New Zealand: the NITRIC follow-up study protocol.

BMJ open·2023
Same author

A qualitative investigation of paediatric intensive care staff attitudes towards the diagnosis of lower respiratory tract infection in the molecular diagnostics era.

Intensive care medicine. Paediatric and neonatal·2023
Same author

Cardiac manifestations in critically ill patients with COVID-19: do we really know what hit us?

Intensive care medicine·2022

Related Experiment Video

Updated: Nov 22, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K

COVID-19: A new challenge for ECMO.

Paul Nixon1,2, Warwick Butt3,4,5,6

  • 1Intensive Care Unit, Alfred Hospital, Melbourne, VIC, Australia.

Perfusion
|January 8, 2021
PubMed
Summary
This summary is machine-generated.

COVID-19 causes severe cardiorespiratory issues, necessitating extracorporeal membrane oxygenation (ECMO). New strategies are crucial for optimal ECMO support due to hyperinflammation and coagulation problems.

Keywords:
COVIDECMOanticoagulationcannulationpulmonary embolism

More Related Videos

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

584
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

625

Related Experiment Videos

Last Updated: Nov 22, 2025

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
06:41

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse

Published on: October 24, 2018

12.8K
Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
03:40

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

584
Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

625

Area of Science:

  • Critical Care Medicine
  • Cardiology
  • Pulmonology

Background:

  • COVID-19 presents diverse pathophysiology impacting cardiorespiratory function.
  • Conditions include hypoxic respiratory failure, cardiogenic shock, cardiac arrest, and vascular thrombosis.
  • These complications frequently necessitate extracorporeal membrane oxygenation (ECMO) support.

Purpose of the Study:

  • To address the complex challenges in providing ECMO for COVID-19 patients.
  • To explore novel cannulation and management strategies for ECMO in this population.

Main Methods:

  • Review of pathophysiology of COVID-19 affecting cardiorespiratory systems.
  • Analysis of existing ECMO cannulation techniques and their limitations.
  • Discussion of hyperinflammation and coagulation abnormalities in COVID-19 patients on ECMO.

Main Results:

  • COVID-19 induces multiple conditions requiring ECMO, such as respiratory failure and shock.
  • Hyperinflammation and coagulopathy complicate ECMO management.
  • Standard ECMO strategies may be insufficient, requiring adaptation.

Conclusions:

  • Optimal ECMO support for COVID-19 necessitates tailored strategies.
  • Addressing hyperinflammation and coagulation is key to improving outcomes.
  • Further research into novel ECMO approaches is warranted.